Becton Dickinsonvs.Medtronic
BDX vs MDT · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Medtronic is about 2.3× larger than Becton Dickinson by market cap; Medtronic trades at the lower P/E (24.2 vs 53.2); year to date, Becton Dickinson leads (+25.0% vs −3.3%).
Side by side
| BDX | MDT | |
|---|---|---|
| Market cap | $50.1B | $116B |
| Price | $189.78 | $91.14 |
| Today | −0.5% | −1.9% |
| Return YTD | +25.0% | −3.3% |
| Return 1Y | +21.5% | +0.2% |
| P/E | 53.2 | 24.2 |
| P/S | 2.4 | 3.2 |
| P/B | 2.1 | 2.4 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
Becton DickinsonBDX
Syringes and needles sit at the recognisable end of the range. Becton Dickinson's portfolio is broad, spanning medical consumables alongside diagnostic systems and drug delivery equipment.
Full BDX profile →MedtronicMDT
Cardiac rhythm and cardiology devices anchor a catalogue that also runs through surgical equipment, neurology and diabetes treatment.
Full MDT profile →More BDX & MDT comparisons
Other head-to-heads in the Medtech & devices segment.